StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Citi initiates Jazz Pharmaceuticals coverage with Buy rating
September 30, 2026 5:01 AM
(Updated - September 30, 2026 5:05 AM EDT)
Citi analyst Geoff M initiated coverage on Jazz Pharmaceuticals (NASDAQ: JAZZ) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
New Coverage